Thomas O'Neil

Thomas O'Neil

Geen lopende functies
61 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Thomas P.
O'Neil
worked as Vice President-Finance & Administration at Nodality, Inc. from 2007 to 2009 and at ChemGenex Pharmaceuticals Pty Ltd. from 2009 to 2011.
In 2014, served as Chief Financial Officer & Media Relations Contact at Sorbent Therapeutics, Inc. Held the position of Chief Financial Officer at Arcadia Biosciences, Inc. in 2015.
From 2016 to 2019, was Chief Financial & Accounting Officer at Protagonist Therapeutics, Inc., and from 2019 to 2023, held the same title at Satsuma Pharmaceuticals, Inc. Other roles include Director-Financial Planning & Analysis at Monogram Biosciences, Inc., Vice President-Finance & Administration at HX Diagnostics, Inc., and Principal at Autodesk, Inc., Nellcor, Inc., Miller Freeman, Inc., Covidien LP, and ASM Group, Inc. Education includes undergraduate studies at Pomona College and an MBA from UCLA Anderson School of Management.

Eerdere bekende functies van Thomas O'Neil

BedrijvenFunctieEinde
SATSUMA PHARMACEUTICALS, INC. Financieel Directeur/CFO 08-06-2023
PROTAGONIST THERAPEUTICS, INC. Financieel Directeur/CFO 11-01-2019
ARCADIA BIOSCIENCES, INC. Financieel Directeur/CFO 16-10-2015
Financieel Directeur/CFO 01-07-2014
Financieel Directeur/CFO 01-08-2011
Ervaring van Thomas O'Neil in detail bekijken

Opleiding van Thomas O'Neil

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

30

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Technology Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Nellcor, Inc.

Health Technology

Commercial Services

Health Technology

Process Industries

Health Services

Transportation

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Thomas O'Neil
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU